Chris Newmarker

Abbott (NYSE: ABT) is turning to Google's artificial intelligence expertise to leverage more blood glucose insights for users of the Abbott Park, Illinois–based life science giant's Lingo biowearable.

Cardinal Health today released Q4 results that handily beat the Wall Street consensus on profits, even as it missed on revenue.

Intuitive Surgical's da Vinci 5 is the device developer's fifth-generation surgical robotics system. [Image courtesy of Intuitive Surgical] Oppenheimer

[Image from Pixabay] Abbott (NYSE: ABT) has filed a motion opposing the creation of a multidistrict litigation that would consolidate 23

Activist investor Sessa Capital has taken a sizeable stake in long-term, implantable CGM company Senseonics (NYSE: SENS), according to an SEC Schedule 13G filed today.

The NexSys PCS system. [Image courtesy of Haemonetics] Haemonetics (NYSE: HAE) is reconnecting with CSL Plasma, with a new deal to supply the donation collection provider with its latest hardware.

Smith+Nephew CFO John Rogers plans to step down from his post at the British medtech giant and take up a new job at an undisclosed U.S. firm.

A Michigan-based activist investor is urging CVRx (NASDAQ: CVRx) — the maker of the heart-failure-symptom-treating implantable Barostim system — to sell to a strategic acquirer.

With less than a week until Medtronic (NYSE: MDT) announces its first-quarter earnings, the world's largest medtech company has been riding rising stock and analyst upgrades.

As a much-awaited Q1 earnings report approaches, here are the top stories of what has so far been a mostly positive year for Minnesota-run Medtronic.